• 四川大學(xué)華西醫(yī)院肝膽胰外科( 四川成都 610041 );

目的  探討Ⅳ型肝門部膽管癌的初步治療經(jīng)驗(yàn)。
方法  收集2008年4月至2011年4月期間四川大學(xué)華西醫(yī)院肝膽胰外科1個(gè)醫(yī)療組收治的20例Ⅳ型肝門部膽管癌患者的臨床資料,對(duì)其術(shù)中及術(shù)后結(jié)果進(jìn)行分析。
結(jié)果  20例中行手術(shù)切除15例,切除率為75%。其中行根治性切除術(shù)10例,非根治性切除術(shù)5例;行左三肝+尾葉切除(右前右后肝管成形、肝管-空腸吻合+空腸-空腸Roux-en-Y吻合術(shù))7例,行擴(kuò)大右半肝切除+尾葉切除(左外左內(nèi)肝管成形、肝管-空腸吻合+空腸-空腸Roux-en-Y吻合術(shù))6例,行肝方葉切除(左外內(nèi)、右前后肝管分別整形后行2個(gè)膽-腸吻合術(shù))2例;其中2例因總膽紅素>400 mmol/L而先行經(jīng)皮肝穿刺膽管引流(PTCD)和門靜脈栓塞(PVE)后再手術(shù),1例行根治性切除術(shù),另1例行非根治性切除術(shù)。不能切除者5例,其中3例因發(fā)生肝臟及遠(yuǎn)處廣泛轉(zhuǎn)移,行術(shù)中PTCD,另2例因腫瘤侵犯門靜脈左右支,行術(shù)中T管引流、聯(lián)合術(shù)后PTCD。行手術(shù)切除者術(shù)后1年生存率為100%,術(shù)后生存時(shí)間1~3年,平均1.5年;腫瘤未切除者生存3~6個(gè)月,平均4.2個(gè)月。本組無一例圍手術(shù)期死亡。
結(jié)論  對(duì)于Ⅳ型肝門部膽管癌,術(shù)前應(yīng)精確評(píng)估,力爭(zhēng)切除腫瘤,解除膽管梗阻;如不能一期切除則行PTCD和PVE,力爭(zhēng)二期切除。

引用本文: 王春,陳哲宇,曾勇,嚴(yán)律南. Ⅳ型肝門部膽管癌的治療體會(huì). 中國(guó)普外基礎(chǔ)與臨床雜志, 2012, 19(1): 62-65. doi: 復(fù)制

版權(quán)信息: ?四川大學(xué)華西醫(yī)院華西期刊社《中國(guó)普外基礎(chǔ)與臨床雜志》版權(quán)所有,未經(jīng)授權(quán)不得轉(zhuǎn)載、改編

1. Friman S. Cholangiocarcinoma - current treatment options [J].Scand J Surg, 2011, 100(1):30-34.
2. 黃志強(qiáng). 肝門部膽管癌外科治療 [J]. 臨床外科雜志, 2006,14(2):65-66..
3. Deoliveira ML, Schulick RD, Nimura Y, et al. New staging sys中國(guó)普外基礎(chǔ)與臨床雜志2012 年1 月第19 卷第1 期 Chin J Bases Clin General Surg, Vol. 19, No. 1, Jan. 2012 ? 65 ?tem and a registry for perihilar cholangiocarcinoma [J]. Hepatology,2011, 53(4): 1363-1371.
4. Agrawal S, Belghiti J. Oncologic resection for malignant tumors of the liver [J]. Ann Surg, 2011, 253(4): 656-665.
5. 梁廷波.肝門部膽管癌外科治療的幾個(gè)問題 [J].中國(guó)普外基礎(chǔ)與臨床雜志, 2011, 18(6): 572-575..
6. 耿小平.肝門部膽管癌外科治療的爭(zhēng)議與進(jìn)展 [J].中國(guó)普外基礎(chǔ)與臨床雜志, 2011, 18(6): 569-571..
7. Zografos GN, Farfaras A, Zagouri F, et al. Cholangiocarcinoma:principles and current trends [J]. Hepatobiliary Pancreat Dis Int,2011, 10(1): 10-20.
8. 黃志強(qiáng).肝門部膽管癌外科治療25 年的歷程 [J].中華消化外科雜志, 2010, 9(3):161-164..
9. 何強(qiáng), 梁力建.肝門部膽管癌外科治療的若干問題 [J].中國(guó)普外基礎(chǔ)與臨床雜志, 2009, 16(11): 869-872..
10. Yi B, Xu AM, Lai EC, et al. Preoperative portal vein embolizati on for hilar cholangiocarcinoma— a comparative study [J]. Hepatogastroenterology,2010, 57(104): 1341-1346.
11. Kaiser GM, Sotiropoulos GC, Sgourakis G, et al. Surgical treatment of Klatskin tumor:liver resection versus transplantation [J]. Hepatogastroenterology, 2010, 57(104): 1337-1340.
12. 易濱, 姜小清.肝門部膽管癌的計(jì)劃性肝切除 [J].中國(guó)普外基礎(chǔ)與臨床雜志, 2011, 18(6): 576-578..
13. 周寧新, 黃志強(qiáng), 張文智, 等.402 例肝門部膽管癌臨床分型、手術(shù)方式與遠(yuǎn)期療效的綜合分析 [J]. 中華外科雜志, 2006,44 (23): 1599-1603..
14. 胡超華, 胡若男, 熊杰, 等.肝門部膽管癌的手術(shù)治療 [J]. 中國(guó)普外基礎(chǔ)與臨床雜志, 2009, 16(11): 873-874..
15. van Gulik TM, Ruys AT, Busch OR, et al. Extent of liver resection for hilar cholangiocarcinoma (Klatskin tumor): how much is enough? [J]. Dig Surg, 2011, 28(2): 141-147.
16. Akamatsu N, Sugawara Y, Hashimoto D. Surgical strategy for bile duct Cancer: Advances and current limitations [J]. World J Clin Oncol, 2011, 2(2): 94-107.
17. Hong JC, Jones CM, Duffy JP, et al. Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma:a 24-year experience in a single center [J]. Arch Surg, 2011, 146(6): 683-689.
18. Patel SH, Kooby DA, Staley CA 3rd, et al. The prognostic importance of lymphovascular invasion in cholangiocarcinoma above the cystic duct: a new selection criterion for adjuvant therapy? [J]. HPB (Oxford) , 2011, 13(9): 605-611.
19. Saxena A, Chua TC, Chu FC, et al. Improved outcomes after aggressive surgical resection of hilar cholangiocarcinoma: a critical analysis of recurrence and survival [J]. Am J Surg,2011, 202(3): 310-320.
20. 杜希臣, 金星林.Ⅲ, Ⅳ型肝門膽管癌切除術(shù)空腸前唇與肝面吻合應(yīng)用價(jià)值研究 [J].中國(guó)實(shí)用外科雜志, 2010, 30(4): 307-308..
21. Sasaki R, Kondo T, Oda T, et al. Impact of three-dimensional analysis of multidetector row computed tomography cholangioportography in operative planning for hilar cholangiocarcinoma [J]. Am J Surg, 2011, 202(4): 441-448.
22. 成雨, 陳鴻強(qiáng), 戴劍, 等肝切除、肝門-空腸吻合治療Bismuth Ⅳ肝門部膽管癌 [J].中華普通外科雜志, 2010, 25(4): 269-272.
23. Regimbeau JM, Fuks D, Le Treut YP, et al. Surgery for hilarcholangiocarcinoma:a multi-institutional update on practice and outcome by the AFC-HC study group [J]. J Gastrointest Surg,2011, 15(3): 480-488.
24. Hong YK, Choi SB, Lee KH, et al. The efficacy of portal vein embolization prior to right extended hemihepatectomy for hilar cholangiocellular carcinoma: a retrospective cohortstudy [J]. Eur J Surg Oncol, 2011, 37(3): 237-244.
25. 王堅(jiān), 王輝, 王昊陸.提高肝門部膽管癌療效的思考 [J].中華消化外科雜志, 2010, 9(3): 177-179..
26. Mihalache F, Tantau M, Diaconu B, et al. Survival and quality of life of cholangiocarcinoma patients:a prospective study over a 4 year period [J]. J Gastrointestin Liver Dis, 2010, 19(3): 285-290.
  1. 1. Friman S. Cholangiocarcinoma - current treatment options [J].Scand J Surg, 2011, 100(1):30-34.
  2. 2. 黃志強(qiáng). 肝門部膽管癌外科治療 [J]. 臨床外科雜志, 2006,14(2):65-66..
  3. 3. Deoliveira ML, Schulick RD, Nimura Y, et al. New staging sys中國(guó)普外基礎(chǔ)與臨床雜志2012 年1 月第19 卷第1 期 Chin J Bases Clin General Surg, Vol. 19, No. 1, Jan. 2012 ? 65 ?tem and a registry for perihilar cholangiocarcinoma [J]. Hepatology,2011, 53(4): 1363-1371.
  4. 4. Agrawal S, Belghiti J. Oncologic resection for malignant tumors of the liver [J]. Ann Surg, 2011, 253(4): 656-665.
  5. 5. 梁廷波.肝門部膽管癌外科治療的幾個(gè)問題 [J].中國(guó)普外基礎(chǔ)與臨床雜志, 2011, 18(6): 572-575..
  6. 6. 耿小平.肝門部膽管癌外科治療的爭(zhēng)議與進(jìn)展 [J].中國(guó)普外基礎(chǔ)與臨床雜志, 2011, 18(6): 569-571..
  7. 7. Zografos GN, Farfaras A, Zagouri F, et al. Cholangiocarcinoma:principles and current trends [J]. Hepatobiliary Pancreat Dis Int,2011, 10(1): 10-20.
  8. 8. 黃志強(qiáng).肝門部膽管癌外科治療25 年的歷程 [J].中華消化外科雜志, 2010, 9(3):161-164..
  9. 9. 何強(qiáng), 梁力建.肝門部膽管癌外科治療的若干問題 [J].中國(guó)普外基礎(chǔ)與臨床雜志, 2009, 16(11): 869-872..
  10. 10. Yi B, Xu AM, Lai EC, et al. Preoperative portal vein embolizati on for hilar cholangiocarcinoma— a comparative study [J]. Hepatogastroenterology,2010, 57(104): 1341-1346.
  11. 11. Kaiser GM, Sotiropoulos GC, Sgourakis G, et al. Surgical treatment of Klatskin tumor:liver resection versus transplantation [J]. Hepatogastroenterology, 2010, 57(104): 1337-1340.
  12. 12. 易濱, 姜小清.肝門部膽管癌的計(jì)劃性肝切除 [J].中國(guó)普外基礎(chǔ)與臨床雜志, 2011, 18(6): 576-578..
  13. 13. 周寧新, 黃志強(qiáng), 張文智, 等.402 例肝門部膽管癌臨床分型、手術(shù)方式與遠(yuǎn)期療效的綜合分析 [J]. 中華外科雜志, 2006,44 (23): 1599-1603..
  14. 14. 胡超華, 胡若男, 熊杰, 等.肝門部膽管癌的手術(shù)治療 [J]. 中國(guó)普外基礎(chǔ)與臨床雜志, 2009, 16(11): 873-874..
  15. 15. van Gulik TM, Ruys AT, Busch OR, et al. Extent of liver resection for hilar cholangiocarcinoma (Klatskin tumor): how much is enough? [J]. Dig Surg, 2011, 28(2): 141-147.
  16. 16. Akamatsu N, Sugawara Y, Hashimoto D. Surgical strategy for bile duct Cancer: Advances and current limitations [J]. World J Clin Oncol, 2011, 2(2): 94-107.
  17. 17. Hong JC, Jones CM, Duffy JP, et al. Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma:a 24-year experience in a single center [J]. Arch Surg, 2011, 146(6): 683-689.
  18. 18. Patel SH, Kooby DA, Staley CA 3rd, et al. The prognostic importance of lymphovascular invasion in cholangiocarcinoma above the cystic duct: a new selection criterion for adjuvant therapy? [J]. HPB (Oxford) , 2011, 13(9): 605-611.
  19. 19. Saxena A, Chua TC, Chu FC, et al. Improved outcomes after aggressive surgical resection of hilar cholangiocarcinoma: a critical analysis of recurrence and survival [J]. Am J Surg,2011, 202(3): 310-320.
  20. 20. 杜希臣, 金星林.Ⅲ, Ⅳ型肝門膽管癌切除術(shù)空腸前唇與肝面吻合應(yīng)用價(jià)值研究 [J].中國(guó)實(shí)用外科雜志, 2010, 30(4): 307-308..
  21. 21. Sasaki R, Kondo T, Oda T, et al. Impact of three-dimensional analysis of multidetector row computed tomography cholangioportography in operative planning for hilar cholangiocarcinoma [J]. Am J Surg, 2011, 202(4): 441-448.
  22. 22. 成雨, 陳鴻強(qiáng), 戴劍, 等肝切除、肝門-空腸吻合治療Bismuth Ⅳ肝門部膽管癌 [J].中華普通外科雜志, 2010, 25(4): 269-272.
  23. 23. Regimbeau JM, Fuks D, Le Treut YP, et al. Surgery for hilarcholangiocarcinoma:a multi-institutional update on practice and outcome by the AFC-HC study group [J]. J Gastrointest Surg,2011, 15(3): 480-488.
  24. 24. Hong YK, Choi SB, Lee KH, et al. The efficacy of portal vein embolization prior to right extended hemihepatectomy for hilar cholangiocellular carcinoma: a retrospective cohortstudy [J]. Eur J Surg Oncol, 2011, 37(3): 237-244.
  25. 25. 王堅(jiān), 王輝, 王昊陸.提高肝門部膽管癌療效的思考 [J].中華消化外科雜志, 2010, 9(3): 177-179..
  26. 26. Mihalache F, Tantau M, Diaconu B, et al. Survival and quality of life of cholangiocarcinoma patients:a prospective study over a 4 year period [J]. J Gastrointestin Liver Dis, 2010, 19(3): 285-290.